Sellas Life Sciences Group Inc (SLS)
SG&A Expense Growth
5.68%
Quarterly · Period ending:
SLS SG&A Expense Growth
Latest reported5.68%period ending
Latest reported5.68%period ending
SLS Quarterly SG&A Growth (QoQ) (0.00% → 5.68%)
Latest values, visible window
High-resolution chart · PNG
SLS sg&a expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 5.6755% | |
| 16.9645% | |
| 22.9508% | |
| -4.497% | |
| 5.0385% | |
| 15.1955% | |
| -16.3802% | |
| 21.848% | |
| -46.2947% | |
| 47.2078% | |
| -13.1905% | |
| 13.4634% | |
| -23.8617% | |
| 14.0833% | |
| 25.6983% | |
| -7.4337% | |
| 2.3148% | |
| 19.715% | |
| 3.6946% | |
| -12.9067% | |
| -21.4546% | |
| 8.3029% | |
| 54.7294% | |
| 6.9451% | |
| -9.6818% | |
| -8.3333% | |
| 0.6289% | |
| -9.5906% | |
| 5.52% | |
| -5.3747% | |
| 97.0172% | |
| -72.6828% | |
| 26.5206% | |
| -35.1713% | |
| 70.4643% | |
| 22.4625% | |
| 5.1724% | |
| 8.3035% | |
| -11.6222% | |
| -8.6301% | |
| -11.5745% | |
| 28.6496% | |
| -5.3541% | |
| -55.1232% | |
| 108.9731% | |
| -59.6259% | |
| 115.8667% | |
| -63.1042% | |
| 40.5564% | |
| 9.6132% | |
| 50.9082% | |
| 76.7551% | |
| 52.6797% | |
| 0.857% | |
| 11.6262% | |
| -30.7692% | |
| 12.4284% | |
| 525.8065% | |
| -86.5477% | |
| 6.4135% | |
| -37.512% | |
| 60.0308% | |
| 9.3102% | |
| -45.474% | |
| 29.249% | |
| -16.7763% | |
| 60.7615% | |
| -7.7111% | |
| -25.6261% | |
| 50.3001% | |
| -21.9336% | |
| 48.6076% | |
| -2.7692% | |
| 18.1818% | |
| 25.3418% | |
| -2.2282% | |
| 90.8163% | |
| 72.9412% | |
| 0% |